Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience

被引：18

作者：

Wei, Shuanzeng ^{[1
,2
]}

LiVolsi, Virginia A. ^{[1
]}

Montone, Kathleen T. ^{[1
]}

Morrissette, Jennifer J. D. ^{[3
]}

Baloch, Zubair W. ^{[1
]}

机构：

[1] Hosp Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA

[2] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA

[3] Hosp Univ Penn, Dept Pathol & Lab Med, 3020 Market St, Philadelphia, PA 19104 USA

来源：

ENDOCRINE PATHOLOGY | 2016年 / 27卷 / 04期

关键词：

Medullary thyroid carcinoma; RET; HRAS; Mutation; ENDOCRINE NEOPLASIA TYPE-2; RET PROTOONCOGENE; RAS MUTATIONS; CANCER; MANAGEMENT; SPECTRUM;

D O I：

10.1007/s12022-016-9446-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Medullary thyroid carcinoma (MTC) harbors rearranged during transfection (RET) gene and rarely RAS gene mutations. The knowledge of the type of gene mutation in MTC is important to determine the treatment of the patients and the management of their family members. Targeted next-generation sequencing with a panel of 47 genes was performed in a total of 12 cases of sporadic (9/12) and hereditary MTC (3/12). Two of three hereditary MTCs had RET/C634R mutation, while the other one harbored two RET mutations (L790F and S649L). All the sporadic MTC had RET/M918T mutation except one case with HRAS mutation. Next-generation sequencing (NGS) can provide comprehensive analysis of molecular alterations in MTC in a routine clinical setting, which facilitate the management of the patient and the family members.

引用

页码：359 / 362

页数：4

共 33 条

[1] College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests [J].

Aziz, Nazneen ;

Zhao, Qin ;

Bry, Lynn ;

Driscoll, Denise K. ;

Funke, Birgit ;

Gibson, Jane S. ;

Grody, Wayne W. ;

Hegde, Madhuri R. ;

Hoeltge, Gerald A. ;

Leonard, Debra G. B. ;

Merker, Jason D. ;

Nagarajan, Rakesh ;

Palicki, Linda A. ;

Robetorye, Ryan S. ;

Schrijver, Iris ;

Weck, Karen E. ;

Voelkerding, Karl V. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (04) :481-493

[2] The clinical spectrum of RET proto-oncogene mutations in codon 790 [J].

Bihan, Helene ;

Murat, Arnaud ;

Fysekidis, Marinos ;

Al-Salameh, Abdallah ;

Schwartz, Claire ;

Baudin, Eric ;

Thieblot, Philippe ;

Borson-Chazot, Francoise ;

Guillausseau, Pierre-Jean ;

Cardot-Bauters, Catherine ;

Raingeard, Isabelle ;

Requeda, Elisabeth ;

Sadoul, Jean Louis ;

Reznik, Yves .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (03) :271-276

[3] Somatic RAS Mutations Occur in a Large Proportion of Sporadic RET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon [J].

Boichard, A. ;

Croux, L. ;

Al Ghuzlan, A. ;

Broutin, S. ;

Dupuy, C. ;

Leboulleux, S. ;

Schlumberger, M. ;

Bidart, J. M. ;

Lacroix, L. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10) :E2031-E2035

[4] The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer [J].

Chen, Herbert ;

Sippel, Rebecca S. ;

O'Dorisio, M. Sue ;

Vinik, Aaron I. ;

Lloyd, Ricardo V. ;

Pacak, Karel .

PANCREAS, 2010, 39 (06) :775-783

[5] Molecular Pathology of Hereditary and Sporadic Medullary Thyroid Carcinomas [J].

Chernock, Rebecca D. ;

Hagemann, Ian S. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (06) :768-777

[6] Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series [J].

Ciampi, Raffaele ;

Mian, Caterina ;

Fugazzola, Laura ;

Cosci, Barbara ;

Romei, Cristina ;

Barollo, Susi ;

Cirello, Valentina ;

Bottici, Valeria ;

Marconcini, Giulia ;

Rosa, Pelizzo Maria ;

Borrello, Maria Grazia ;

Basolo, Fulvio ;

Ugolini, Clara ;

Materazzi, Gabriele ;

Pinchera, Aldo ;

Elisei, Rossella .

THYROID, 2013, 23 (01) :50-57

[7] Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma [J].

Colombo-Benkmann, Mario ;

Li, Zhenpeng ;

Riemann, Burkhard ;

Hengst, Karin ;

Herbst, Hermann ;

Keuser, Roger ;

Gross, Ute ;

Rondot, Susanne ;

Raue, Friedhelm ;

Senninger, Norbert ;

Puetzer, Brigitte M. ;

Frank-Raue, Karin .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (06) :811-816

[8]

DeLellis R.A., 2004, Pathology and genetics of tumours of endocrine organs, V8

[9] Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas [J].

Dvorakova, S. ;

Vaclavikova, E. ;

Sykorova, V. ;

Vcelak, J. ;

Novak, Z. ;

Duskova, J. ;

Ryska, A. ;

Laco, J. ;

Cap, J. ;

Kodetova, D. ;

Kodet, R. ;

Krskova, L. ;

Vlcek, P. ;

Astl, J. ;

Vesely, D. ;

Bendlova, B. .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 284 (1-2) :21-27

[10] Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form [J].

Figlioli, Gisella ;

Landi, Stefano ;

Romei, Cristina ;

Elisei, Rossella ;

Gemignani, Federica .

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2013, 752 (01) :36-44

← 1 2 3 4 →